Ajanta Pharma Limited, a active public limited company, was established on 31 December 1979 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24230MH1979PLC022059. Registered under ROC Roc Mumbai. it is listed on BSE: 532331 and NSE: AJANTPHARM. It has an authorized capital of ₹30.00 Cr and a paid-up capital of ₹24.99 Cr.
Formerly known as Ajanta Pharma Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹4,087.60 Cr and a net worth of ₹3,413.57 Cr. Employing 7,869 professional, Its leadership includes David Paul Rasquinha (Director), Simi Manohar Lal Thapar (Director), Rajesh Shashikant Dalal (Director). Past directors included Napoleon Chelliah, Chandrakant Mohanlal Khetan, Manjiri Manohar Bhalerao. It holds ₹65.00 Cr open charges and ₹548.84 Cr settled loans. Its latest AGM occurred on 17 July 2025, with the balance sheet filed on 31 March 2025. It is based at Ajanta House 98 Govtindustrial Area Charkop Kandivli(West), Mumbai, Maharashtra, 400067.
L24230MH1979PLC022059
022059
31 December 1979
₹30.00 Cr
₹24.99 Cr
Roc Mumbai
Listed (BSE: 532331, NSE: AJANTPHARM)
Active
Explore comprehensive insights into Ajanta Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| David Paul Rasquinha | Director | 02 May 2024 | Current |
| Simi Manohar Lal Thapar | Director | 02 May 2024 | Current |
| Rajesh Shashikant Dalal | Director | 02 May 2024 | Current |
| Madhusudan Bhagwandas Agrawal | Whole-Time Director | 31 Dec 1979 | Current |
| Medha Vinay Joshi | Director | 02 May 2024 | Current |
| Mannalal Bhagwandas Agrawal | Director | 31 Dec 1979 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | 17 Jan 2009 | Past |
| Pramod Abcsdd | Director | 17 Jul 2019 | Past |
| Pramod Abcsdd | Nominee Director | 30 Apr 2011 | Past |
| Pramod Abcsdd | Director | 17 Jul 2019 | Past |
| Pramod Abcsdd | Additional Director | 17 Jul 2024 | Past |
| Pramod Abcsdd | Additional Director | 17 Jul 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ajanta Pharma Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 15.34% increase. The company also saw a substantial improvement in profitability, with a 44.48% increase in profit. The company's net worth moved up by a moderate rise of 5.15%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Ajanta Pharma had a promoter holding of 66.22% and a public holding of 33.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹650,000,000.00
₹5,488,389,073.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jan 2024 | Idbi Bank Limited | ₹10.00 Cr | Open |
| 11 Feb 2021 | Others | ₹10.00 Cr | Open |
| 26 Jun 2020 | Citi Bank N.A. | ₹35.00 Cr | Open |
| 03 Jul 1997 | Others | ₹10.00 Cr | Open |
| 21 Mar 2013 | State Bank Of Mauritius Limited | ₹55.16 Cr | Satisfied |
Explore comprehensive loan charge details -
Ajanta Pharma has a workforce of 7869 employees as of Aug 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ajanta Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ajanta Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Ajanta Pharma Limited last Annual general meeting of members was held on 17 Jul 2025 as per latest MCA records. was completed.
Ajanta Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
Progress on David Paul Rasquinha was appointed as a Director was appointed as a Director on 02 May 2024 & has been associated with this company since 1 year 6 months . was documented.
Simi Manohar Lal Thapar was appointed as a Director was appointed as a Director on 02 May 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.
Rajesh Shashikant Dalal was appointed as a Director was appointed as a Director on 02 May 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.
Medha Vinay Joshi was appointed as a Director was appointed as a Director on 02 May 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.
The CIN of Ajanta Pharma Limited is L24230MH1979PLC022059.
Ajanta Pharma Limited is headquartered at Ajanta House 98 Govtindustrial Area Charkop Kandivli(West), Mumbai, Maharashtra, 400067.
Ajanta Pharma Limited was incorporated on 31 December 1979.
The current directors of Ajanta Pharma Limited are
The primary industry of Ajanta Pharma Limited is Manufacturing.
Ajanta Pharma Limited is listed. It is listed on BSE: 532331 and NSE: AJANTPHARM.
The authorized capital of Ajanta Pharma Limited is ₹30.00 Cr, and the paid-up capital is ₹24.99 Cr.
The compliance status of Ajanta Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX